Jane Street Group, LLC Compugen LTD Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.75 - $2.95 $254,360 - $428,779	145,349 New	145,349 $375,000
Q1 2023 May 15, 2023	SELL	$0.68 - $1.11 $26,910 - $43,927	-39,574 Reduced 30.46%	90,329 $63,000
Q4 2022 Feb 14, 2023	BUY	$0.58 - $1.2 $12,021 - $24,872	20,727 Added 18.98%	129,903 $93,000
Q3 2022 Nov 14, 2022	BUY	$0.66 - $2.32 $23,063 - $81,072	34,945 Added 47.08%	109,176 $72,000
Q2 2022 Aug 16, 2022	SELL	$1.57 - $3.33 $66,442 - $140,925	-42,320 Reduced 36.31%	74,231 $137,000
Q1 2022 May 17, 2022	BUY	$2.76 - $4.64 $84,458 - $141,988	30,601 Added 35.6%	116,551 $375,000
Q4 2021 Feb 15, 2022	BUY	$4.09 - $7.16 $282,901 - $495,250	69,169 Added 412.19%	85,950 $370,000
Q3 2021 Nov 16, 2021	SELL	$5.8 - $8.02 $504,147 - $697,114	-86,922 Reduced 83.82%	16,781 $100,000
Q2 2021 Aug 16, 2021	SELL	$6.87 - $9.16 $344,571 - $459,428	-50,156 Reduced 32.6%	103,703 $859,000
Q1 2021 May 18, 2021	BUY	$7.67 - $13.77 $243,123 - $436,481	31,698 Added 25.95%	153,859 $1.32 Million
Q4 2020 Feb 17, 2021	BUY	$12.07 - $17.95 $856,776 - $1.27 Million	70,984 Added 138.7%	122,161 $1.48 Million
Q3 2020 Nov 17, 2020	SELL	$14.16 - $19.45 $713,763 - $980,416	-50,407 Reduced 49.62%	51,177 $832,000
Q2 2020 Aug 17, 2020	BUY	$6.97 - $17.12 $494,166 - $1.21 Million	70,899 Added 231.05%	101,584 $1.53 Million
Q1 2020 May 15, 2020	SELL	$5.79 - $11.83 $315,485 - $644,593	-54,488 Reduced 63.97%	30,685 $223,000
Q4 2019 Feb 14, 2020	SELL	$3.9 - $6.16 $63,480 - $100,266	-16,277 Reduced 16.04%	85,173 $508,000
Q3 2019 Nov 14, 2019	BUY	$3.01 - $4.49 $107,544 - $160,423	35,729 Added 54.36%	101,450 $429,000
Q2 2019 Aug 15, 2019	BUY	$2.8 - $4.14 $31,337 - $46,334	11,192 Added 20.52%	65,721 $252,000
Q1 2019 May 16, 2019	BUY	$2.35 - $4.19 $65,659 - $117,068	27,940 Added 105.08%	54,529 $226,000
Q4 2018 Feb 15, 2019	SELL	$2.17 - $3.8 $14,647 - $25,650	-6,750 Reduced 20.25%	26,589 $58,000
Q3 2018 Nov 14, 2018	BUY	$3.0 - $4.05 $100,017 - $135,022	33,339 New	33,339 $128,000
Q2 2018 Aug 15, 2018	SELL	$3.15 - $4.7 $327,042 - $487,968	-103,823 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.5 - $4.45 $68,035 - $121,102	27,214 Added 35.52%	103,823 $462,000
Q4 2017 Feb 15, 2018	BUY	$2.35 - $4.0 $180,031 - $306,436	76,609	76,609 $192,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.1M

Call Options Held

79.2K

Put Options Held

12.7K

Silverarc Capital Management, LLC

1.5M
Shares

$2.24 Million
0.68% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.29M
Shares

$1.92 Million
0.0% of portfolio
Taylor Frigon Capital Management LLC

1.2M
Shares

$1.79 Million
1.09% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

1.09M
Shares

$1.63 Million
0.02% of portfolio
Macquarie Group LTD Australia, C3

1.02M
Shares

$1.52 Million
0.0% of portfolio

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $129M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account